Cargando…

Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997487/
http://dx.doi.org/10.1007/s40278-021-93003-3
_version_ 1783670340404117504
collection PubMed
description
format Online
Article
Text
id pubmed-7997487
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-79974872021-03-29 Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine Reactions Weekly News Item Springer International Publishing 2021-03-27 2021 /pmc/articles/PMC7997487/ http://dx.doi.org/10.1007/s40278-021-93003-3 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
title Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
title_full Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
title_fullStr Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
title_full_unstemmed Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
title_short Anaphylaxis in Australia with AstraZeneca's COVID-19 vaccine
title_sort anaphylaxis in australia with astrazeneca's covid-19 vaccine
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997487/
http://dx.doi.org/10.1007/s40278-021-93003-3